A bit of PR courtesy of TD.
According to data provided by Energias Market Research, the global medical cannabis market is expected to grow significantly from USD 8.28 billion in 2017 to USD 28.07 billion in 2024, at a CAGR of 19.1% from 2018 to 2024. Factors driving the growth of the medical cannabis market include growing recognition of medical benefits, increasing demand for cannabis in the treatment of various diseases, and growing number of research and development activities. In the U.S, there are 28 states which have approved the use of cannabis for medical purposes. In major markets like Colorado, California, Alaska, Massachusetts and Nevada, cannabis is legal for recreational use. SinglePoint, Inc. (OTC: SING), United Cannabis Corporation (OTC: CNAB), Surna Inc. (OTC: SRNA), Freedom Leaf, Inc. (OTC: $FRLF), GreenGro Technologies Inc. (OTC: GRNH)
Starting January 1st 2018, the state of California has started legal sales of cannabis products for recreational use. A report by CNBC quotes MedMen CEO and co-founder Adam Bierman, who explains the current state of the industry, "There is so much excitement now around legalization nationally coming in Canada. There is so much excitement about the fact that California, Nevada, Maine and Massachusetts all legalized recreational marijuana... The Canadian public markets offer access to a lot of capital, with a lot of certainty and a lot of speed, and there is this appetite among global investors to invest in a U.S. play... Specifically, global investors want to invest in a U.S. play that has California exposure. Now is the time where it makes the most sense."
Freedom Leaf, Inc. (OTCQB: $FRLF) is the leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry. Last month, the company announced that it has hired Purdue University Biomedical Engineering graduate Nick Shi to oversee the Leafceuticals Inc hemp extraction, distillation and refining laboratory in North Las Vegas. Leafceuticals Inc is Freedom Leaf's wholly-owned extraction and manufacturing division that uses NuAxon CO2 supercritical extraction to manufacture wholesale hemp CBD oil, terpenes, rare cannabinoids, and other valuable byproducts of industrial hemp. In addition to hiring highly-skilled staff, Leafceuticals Inc is also in the process of expanding its facility in North Las Vegas, currently constructing two additional fully-functioning laboratory spaces for hemp CBD extracting, distilling, and refining.
If at first you don't succeed, buy more.
